HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Desir, A. Articles by Dondelinger, R. F. Search for Related Content PubMed PubMed Citation Articles by Desir, A. Articles by Dondelinger, R. F.

Percutaneous sclerotherapy of a giant mediastinal lymphangioma

¹ Depts of Medical Imaging, and ² Medicine, University Hospital of Liège, Liège, Belgium.

CORRESPONDENCE: B. Ghaye, Dept of Medical Imaging, University Hospital of Liège, B 35, B-4000 Liège, Belgium. Fax: 32 43667772. E-mail: bghaye{at}chu.ulg.ac.be

Keywords: Interventional, lymphangioma, lymphangiomatosis, mediastinum, radiology, sclerotherapy

Received: February 6, 2007
Accepted January 29, 2008

The present study reports a case of percutaneous sclerotherapy of a giant mediastinal cystic lymphangioma using Ethibloc® (Ethicon, Norderstedt, Germany) and absolute ethanol in a 59-yr-old female.

The tumour, situated predominantly in a retrocardiac location, caused dyspnoea and dysphagia by compression and was considered unresectable. Follow-up computed tomography 3 yrs after treatment showed a 90% volume reduction of the tumour. The patient is currently asymptomatic.

To the best of the present authors’ knowledge, percutaneous transthoracic sclerotherapy of a mediastinal lymphangioma has not previously been reported in the literature available in English.